Recent data expand the biological effects of prolactin particularly on metabolism, cancer, cardiovascular and immune systems opening new avenues on the clinical implications of prolactin and the consequences of hyperprolactinaemia. This evidence concerns the gene PRL and Increased circulating prolactin concentration.